INDIANAPOLIS, Aug. 27, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced Zepbound ® (tirzepatide) 2.5 mg and 5 mg single-dose vials are available for self …

How do I get Zepbound® (tirzepatide) vials? Zepbound 2.5 and 5 mg vials are available exclusively through LillyDirect's self-pay pharmacy channel for patients with a prescription …

Aug 27, 2024 · Eli Lilly is making tirzepatide, branded as Zepbound for weight loss, available in vials for patients who pay out-of-pocket.

This site provides information about Mounjaro ® (tirzepatide) and Zepbound ® (tirzepatide), our prescription-only, FDA-approved medicines containing tirzepatide.

Dec 14, 2024 · The availability of Zepbound® (tirzepatide) single-dose vials marks a new chapter in the treatment of type 2 diabetes and obesity. By offering a more flexible and efficient means …

• ZEPBOUND is a single-dose vial. • ZEPBOUND is used 1 time each week. • Inject under the skin (subcutaneously) only. • You or another person may inject into your stomach (abdomen) …

Jan 10, 2025 · Zepbound vials and pens contain the same active ingredient (tirzepatide), which is a dual-action GLP-1 and GIP agonist that helps regulate your metabolism. This means you …

Zepbound comes in multiple dosing forms including the Zepbound Pen and the Zepbound Vial. Learn about dosing forms for pen & vial, how to dose and helpful tips.

Jan 1, 2025 · Tirzepatide (Zepbound, Mounjaro) is used for weight loss and type 2 diabetes in adults. The Zepbound brand of tirzepatide is also to treat moderate to severe obstructive sleep …

Aug 27, 2024 · Vials of tirzepatide 2.5 mg and 5 mg will be available at a 50% discount compared with the list price of other incretin-based obesity medications.